9 Meters Biopharma Inc. (NASDAQ: NMTR) open the trading on April 07, 2021, with great promise as it jumped 10.81% to $1.23. During the day, the stock rose to $1.31 and sunk to $1.20 before settling in for the price of $1.11 at the close. Taking a more long-term approach, NMTR posted a 52-week range of $0.43-$2.26.
Meanwhile, its Annual Earning per share during the time was 44.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 28.30%. This publicly-traded company’s shares outstanding now amounts to $216.07 million, simultaneously with a float of $175.27 million. The organization now has a market capitalization sitting at $256.98 million. At the time of writing, stock’s 50-day Moving Average stood at $1.5911, while the 200-day Moving Average is $0.9723.
9 Meters Biopharma Inc. (NMTR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. 9 Meters Biopharma Inc.’s current insider ownership accounts for 0.90%, in contrast to 29.30% institutional ownership. According to the most recent insider trade that took place on Apr 05, this organization’s Director bought 300,000 shares at the rate of 1.00, making the entire transaction reach 300,000 in total value, affecting insider ownership by 1,074,066. Preceding that transaction, on Apr 05, Company’s Chief Executive Officer bought 100,000 for 1.00, making the whole transaction’s value amount to 100,000. This particular insider is now the holder of 1,077,522 in total.
9 Meters Biopharma Inc. (NMTR) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2020 suggests? It has posted -$0.05 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.04) by -$0.01. This company achieved a return on equity of -545.95. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
9 Meters Biopharma Inc.’s EPS increase for this current 12-month fiscal period is 28.30% and is forecasted to reach -0.15 in the upcoming year.
9 Meters Biopharma Inc. (NASDAQ: NMTR) Trading Performance Indicators
Let’s observe the current performance indicators for 9 Meters Biopharma Inc. (NMTR). It’s Quick Ratio in the last reported quarter now stands at 5.70. The Stock has managed to achieve an average true range (ATR) of 0.17.
In the same vein, NMTR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.74, a figure that is expected to reach -0.03 in the next quarter, and analysts are predicting that it will be -0.15 at the market close of one year from today.
Technical Analysis of 9 Meters Biopharma Inc. (NMTR)
[9 Meters Biopharma Inc., NMTR] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.13% While, its Average True Range was 0.1673.
Raw Stochastic average of 9 Meters Biopharma Inc. (NMTR) in the period of the previous 100 days is set at 34.81%, which indicates a major rise in contrast to 24.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 136.40% that was higher than 128.60% volatility it exhibited in the past 100-days period.